PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, People\'s Republic of China. guoyu@nankai.edu.cn.\', \'Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People\'s Republic of China.\', \'State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, People\'s Republic of China.\', \'College of Life Science, Nankai University, Tianjin, People\'s Republic of China.\', \'Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, People\'s Republic of China.\', \'HiFiBio (Hong Kong) Limited, Central, Hong Kong.\', \'State Key Laboratory of Virology and National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, People\'s Republic of China.\', \'Wuxi Biologics Limited, Shanghai, People\'s Republic of China.\', \'Shanghai Synchrotron Radiation Facility, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai, People\'s Republic of China.\', \'Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.\', \'Tianjin International Joint Academy of Biotechnology & Medicine, Tianjin, People\'s Republic of China.\', \'MOE Key Laboratory of Protein Science & Collaborative Innovation Center of Biotherapy, School of Medicine, Tsinghua University, Beijing, People\'s Republic of China. louzy@mail.tsinghua.edu.cn.\', \'State Key Laboratory of Virology and National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, People\'s Republic of China. df@wh.iov.cn.\', \'State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, People\'s Republic of China. hongkai@nankai.edu.cn.\', \'College of Life Science, Nankai University, Tianjin, People\'s Republic of China. hongkai@nankai.edu.cn.\', \'Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, People\'s Republic of China. hongkai@nankai.edu.cn.\', \'Frontiers Science Center for Cell Responses, Nankai University, Tianjin, People\'s Republic of China. hongkai@nankai.edu.cn.\', \'State Key Laboratory of Virology and National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, People\'s Republic of China. shanchao@wh.iov.cn.\', \'HiFiBio (Hong Kong) Limited, Central, Hong Kong. l.schweizer@hifibio.com.\', \'Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People\'s Republic of China. sunkun@xinhuamed.com.cn.\', \'State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, People\'s Republic of China. raozh@mail.tsinghua.edu.cn.\', \'College of Life Science, Nankai University, Tianjin, People\'s Republic of China. raozh@mail.tsinghua.edu.cn.\', \'Frontiers Science Center for Cell Responses, Nankai University, Tianjin, People\'s Republic of China. raozh@mail.tsinghua.edu.cn.\', \'Guangzhou Laboratory, Guangzhou, Guangdong, People\'s Republic of China. raozh@mail.tsinghua.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-021-22926-2
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 33976198
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all